Search

Your search keyword '"Tina Parkner"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Tina Parkner" Remove constraint Author: "Tina Parkner" Topic business Remove constraint Topic: business
25 results on '"Tina Parkner"'

Search Results

1. Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults

2. Anti-transglutaminase IgA antibody measurement in coeliac disease: Method comparison IDS-iSYS vs. Thermo Fisher Phadia

3. Plasma neurofilament light chain is associated with mortality after spontaneous intracerebral hemorrhage

4. Plasma Neurofilament Light Chain Is Associated with Poor Functional Outcome and Mortality Rate After Spontaneous Subarachnoid Hemorrhage

5. Diagnostic Accuracy of a Point-of-Care Test for Celiac Disease Antibody Screening among Infertile Patients

6. Reference limits for GAD65 and IA-2 autoantibodies by chemiluminescence immunoassay in Northern European adults and children

7. Home Management of Warfarin Treatment Through a Real-Time Supervised Telemedicine Solution:A Randomized Controlled Trial

8. Unrecognised coeliac disease among men and women undergoing fertility treatment:A screening study

9. A Comparison of ree Chromogranin A Assays in Patients with Neuroendocrine Tumours

10. Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients

11. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes1

12. Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patients

13. Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus

14. Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes

15. Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients

17. A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study

18. IDegAsp:a novel soluble insulin analogs combination

19. Do all patients with type 2 diabetes need breakfast?

20. Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes

21. Overnight versus 24 hours of continuous subcutaneous insulin infusion as supplement to oral antidiabetic drugs in type 2 diabetes

22. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes

23. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

24. P02-46 Diurnal variation in the pharmacokinetics of growth hormone administered as a continuous subcutaneous infusion in GH-deficient subjects

25. Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus

Catalog

Books, media, physical & digital resources